Loading…
IDEAYA Biosciences, Inc. is projected to rise to $42.06 by 2027, a +14% move from its current price of $36.99. IDYA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $35.89 | $36.99 | $38.12 | 0.00% |
| Jul 14 | $35.45 | $36.99 | $38.60 | 0.00% |
| Jul 15 | $35.11 | $36.99 | $38.97 | +0.01% |
| Jul 16 | $34.83 | $36.99 | $39.29 | +0.01% |
| Jul 17 | $34.59 | $36.99 | $39.57 | +0.01% |
| Jul 18 | $34.36 | $37.00 | $39.83 | +0.01% |
| Jul 19 | $34.16 | $37.00 | $40.06 | +0.02% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $34.16 | $37.00 | $40.06 | +0.02% |
| Week 2 | $33.06 | $37.00 | $41.41 | +0.03% |
| Week 3 | $32.24 | $37.01 | $42.48 | +0.05% |
| Week 4 | $31.56 | $37.01 | $43.41 | +0.07% |
| Week 5 | $30.98 | $37.02 | $44.24 | +0.08% |
| Week 6 | $30.46 | $37.03 | $45.00 | +0.10% |
| Week 7 | $30.00 | $37.03 | $45.72 | +0.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
IDEAYA Biosciences, Inc. is a healthcare company focused on precision medicine oncology. It develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.
The company was incorporated in 2015 and is headquartered in South San Francisco, California.
Its portfolio includes several oncology programs such as Darovasertib, an oral PKC inhibitor for the treatment of uveal melanoma and ocular cancer, along with IDE849, IDE034, IDE161, IDE705, IDE397, IDE892, IDE574 and IDE275 as part of its oncology-focused pipeline.
IDEAYA Biosciences, Inc. (IDYA) is currently trading at $39.37 per share.
The company has a market capitalization of $3.79B and is ranked 1580 by market cap.
The price outlook is bullish, supported by a technical picture that includes a current price of $39.37 with a 30-day range of $32.26 to $48.05 and a near-term resistance at $39.37. A near-term support is noted at $27.60.
The 50-day simple moving average is $30.59 and the 200-day simple moving average is $31.79, with an implied annualized volatility of 60%.
A major floor 40.2% below — a decisive break under it would weaken the trend.
The nearest floor, 25.4% below — buyers have tended to step in here.
The nearest ceiling, 9.5% above — a clean break opens room to run.
A major ceiling 29.6% above — clearing it would confirm fresh momentum.
Key IDYA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IDYA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $38.42 | Sell | $37.67 | Sell |
| MA 10 | $37.65 | Sell | $37.16 | Sell |
| MA 20 | $34.97 | Buy | $35.47 | Buy |
| MA 50 | $31.24 | Buy | $33.03 | Buy |
| MA 100 | $31.77 | Buy | $32.15 | Buy |
| MA 200 | $32.05 | Buy | $31.06 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.58 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 45.79 | Neutral |
| Williams %R (14) | -56.05 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 5.96 | Buy |
| Bollinger %B (20,2) | 0.65 | Neutral |
| Stochastic %K (14) | 43.95 | Neutral |
| TRIX (15) | 0.97 | Buy |
| Awesome (5,34) | 5.91 | Buy |
| Ultimate (7,14,28) | 56.25 | Neutral |
| Momentum (10) | 0.70 | Buy |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 38.16 | Sell |
| ADX (14) | 28.85 | Buy |
| ATR (14) | 0.98 | Info |
The 30-day technical picture shows bullish sentiment with RSI14 at 80.
The moving averages point to near-term upside, with SMA50 at $30.59 and SMA200 at $31.79.
The 30-day price range is $32.26–$48.05, with near-term support at $27.60 and resistance at $39.37.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $27.60 | $36.99 | $46.03 | 0% | Neutral | |
| $33.17 | $42.06 | $56.62 | +14% | Neutral | |
| $34.55 | $45.20 | $63.34 | +22% | Bullish | |
| $40.15 | $53.90 | $77.93 | +46% | Bullish | |
| $51.75 | $71.08 | $105.52 | +92% | Bullish | |
| $52.98 | $74.32 | $112.88 | +101% | Bullish | |
| $56.32 | $80.55 | $124.88 | +118% | Bullish | |
| $61.36 | $89.38 | $141.18 | +142% | Bullish | |
| $58.99 | $87.45 | $140.50 | +136% | Bullish | |
| $65.14 | $98.19 | $160.27 | +165% | Bullish | |
| $93.94 | $152.85 | $266.54 | +313% | Bullish | |
| $183.34 | $340.85 | $654.14 | +821% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $27.60 | $36.99 | $44.21 | +0.00% |
| August 2026 | $30.71 | $36.34 | $44.23 | -1.75% |
| September 2026 | $31.08 | $37.07 | $45.67 | +2.00% |
| October 2026 | $31.72 | $38.09 | $47.42 | +2.75% |
| November 2026 | $30.84 | $37.24 | $46.76 | -2.22% |
| December 2026 | $29.97 | $36.38 | $46.03 | -2.33% |
Click any year to see its month-by-month IDYA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect IDYA to range from $27.60 to $46.03 through 2026. The $36.99 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The IDYA price prediction for 2027 points to an average of $42.06 (low $33.17, high $56.62) — a potential gain of +14% on today's $36.99. A consolidation phase looks the most probable path here.
In 2028, IDYA is projected to trade between $34.55 and $63.34, averaging $45.20 — a potential gain of +22% from today's $36.99. That is up +7% on the projected 2027 average. Momentum favours further upside here.
IDEAYA Biosciences, Inc.'s 2029 outlook centres on $53.90, within a $40.15 to $77.93 range. That is up +19% on the projected 2028 average. That marks a +46% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, IDYA could reach as high as $105.52, with a base case around $71.08 and support toward $51.75 — roughly +92% from $36.99. Momentum favours further upside here.
Expect IDYA to range from $52.98 to $112.88 through 2031. The $74.32 average target implies a +101% move from current prices. That is up +5% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The IDYA price prediction for 2032 points to an average of $80.55 (low $56.32, high $124.88) — a potential gain of +118% on today's $36.99. Momentum favours further upside here.
In 2033, IDYA is projected to trade between $61.36 and $141.18, averaging $89.38 — a potential gain of +142% from today's $36.99. That is up +11% on the projected 2032 average. Buyers look set to stay in control over this stretch.
IDEAYA Biosciences, Inc.'s 2034 outlook centres on $87.45, within a $58.99 to $140.50 range. That is -2% versus the projected 2033 average. That marks a +136% change versus current levels. Momentum favours further upside here.
By 2035, IDYA could reach as high as $160.27, with a base case around $98.19 and support toward $65.14 — roughly +165% from $36.99. Buyers look set to stay in control over this stretch.
Expect IDYA to range from $93.94 to $266.54 through 2040. The $152.85 average target implies a +313% move from current prices. That is up +56% on the projected 2035 average. Momentum favours further upside here.
The IDYA price prediction for 2050 points to an average of $340.85 (low $183.34, high $654.14) — a potential gain of +821% on today's $36.99. Buyers look set to stay in control over this stretch.
Investing $1,000 in IDYA today (≈ 27.034334 IDYA) could be worth
$9,214.77
+$8,214.77 (+821%) by 2050 · US Dollar
Based on the average projected IDYA price of $340.85 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IDYAwould be worth at today's price.
$1,000 invested in IDYA on Jul 10, 2025 (≈ 43.859651 IDYA) would be worth
$1,622.37
+$622.37 (+62.2%) today · 1.62× · US Dollar
Based on a IDYA entry price of $22.8 vs. today's $36.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $37.65 | $982.47 | -1.8% |
| 1 month ago | $27.6 | $1,340.22 | +34.0% |
| 3 months ago | $30.5 | $1,212.79 | +21.3% |
| 6 months ago | $36.84 | $1,004.07 | +0.4% |
| 1 year ago | $22.8 | $1,622.37 | +62.2% |
| All time (5.0y) ago | $19.36 | $1,910.64 | +91.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IDYA forecast.
Our base-case forecast reaches $74.00 around 2031.
Implied market cap at $74.00: $7.12B
The multi-year forecast outlines a bullish trajectory through the 2030s and beyond, with specific targets in the 2030, 2040 and 2050 horizons.
For 2030, the average price is projected at $83.50, with a minimum of $60.73 and a maximum of $124.11, representing an ROI of 112.1% and a bullish sentiment.
For 2040, the average is projected at $193.99, with a minimum of $119.02 and a maximum of $338.76, yielding an ROI of 392.7% and a bullish sentiment.
For 2050, the average is projected at $450.68, with a minimum of $241.81 and a maximum of $866.28, yielding an ROI of 1044.7% and a bullish sentiment. These figures illustrate a strong long-run upside while recognizing they are estimates, not guarantees.
Tap a question to reveal the answer.
Year 2030 forecast: min $60.73, avg $83.50, max $124.11 with ROI 112.1% and sentiment BULLISH.
The forecast shows a positive long-run trajectory with rising averages: 2027 avg $46.43 (ROI 17.9%), 2028 avg $50.90 (ROI 29.3%), 2029 avg $62.77 (ROI 59.4%), 2030 avg $83.50 (ROI 112.1%), 2040 avg $193.99 (ROI 392.7%), and 2050 avg $450.68 (ROI 1044.7%). However, these are estimates and not guarantees.
Yes. The forecast for 2033 shows an average price of $108.35 and a max of $171.35, supporting the potential to surpass $100 in the horizon. RSI and other factors are not specified here, only the price forecast data.
Current price is $39.37 per share, and market capitalization is $3.79B.
RSI14 is 80, with SMA50 at $30.59 and SMA200 at $31.79. The 30-day range is $32.26 to $48.05, with support at $27.60 and resistance at $39.37, and a bullish sentiment.
IDEAYA Biosciences, Inc. Community Discussion
0Share your IDEAYA Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.